Diana Hanekamp

MSC.

20132020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7 Article
  • 2 Comment/Letter to the editor
  • 2 Review article
2020

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes

Hanekamp, D., Bachas, C., van de Loosdrecht, A., Ossenkoppele, G. & Cloos, J., 2020, In : Pathology. 52, 2, p. 289-291 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

2019

CD34+CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Zeijlemaker, W., Grob, T., Meijer, R., Hanekamp, D., Kelder, A., Carbaat-Ham, J. C., Oussoren-Brockhoff, Y. J. M., Snel, A. N., Veldhuizen, D., Scholten, W. J., Maertens, J., Breems, D. A., Pabst, T., Manz, M. G., van der Velden, V. H. J., Slomp, J., Preijers, F., Cloos, J., van de Loosdrecht, A. A., Löwenberg, B. & 4 others, Valk, P. J. M., Jongen-Lavrencic, M., Ossenkoppele, G. J. & Schuurhuis, G. J., 1 May 2019, In : Leukemia. 33, 5, p. 1102-1112 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Depreter, B., Weening, K. E., Vandepoele, K., Essand, M., De Moerloose, B., Themeli, M., Cloos, J., Hanekamp, D., Moors, I., D' Hont, I., Denys, B., Uyttebroeck, A., Van Damme, A., Dedeken, L., Snauwaert, S., Goetgeluk, G., De Munter, S., Kerre, T., Vandekerckhove, B., Lammens, T. & 1 others, Philippé, J., 1 Aug 2019, In : Haematologica.

Research output: Contribution to journalArticleAcademicpeer-review

2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Cloos, J., Harris, J. R., Janssen, J. J. W. M., Kelder, A., Huang, F., Sijm, G., Vonk, M., Snel, A. N., Scheick, J. R., Scholten, W. J., Carbaat-Ham, J., Veldhuizen, D., Hanekamp, D., Oussoren-Brockhoff, Y. J. M., Kaspers, G. J. L., Schuurhuis, G. J., Sasser, A. K. & Ossenkoppele, G., 5 Mar 2018, In : Journal of Visualized Experiments. 2018, 133, e56386.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Hanekamp, D., Denys, B., Kaspers, G. J. L., te Marvelde, J. G., Schuurhuis, G. J., de Haas, V., de Moerloose, B., de Bont, E. S., Zwaan, C. M., de Jong, A., Depreter, B., Lammens, T., Philippé, J., Cloos, J. & van der Velden, V. H. J., 2018, In : British Journal of Haematology. 183, 3, p. 512-516

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Jongen-Lavrencic, M., Grob, T., Hanekamp, D., Kavelaars, F. G., Al Hinai, A., Zeilemaker, A., Erpelinck-Verschueren, C. A. J., Gradowska, P. L., Meijer, R., Cloos, J., Biemond, B. J., Graux, C., van Marwijk Kooy, M., Manz, M. G., Pabst, T., Passweg, J. R., Havelange, V., Ossenkoppele, G. J., Sanders, M. A., Schuurhuis, G. J. & 2 others, Löwenberg, B. & Valk, P. J. M., 29 Mar 2018, In : New England Journal of Medicine. 378, 13, p. 1189-1199 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells

Goverse, G., Molenaar, R., MacIa, L., Tan, J., Erkelens, M. N., Konijn, T., Knippenberg, M., Cook, E. C. L., Hanekamp, D., Veldhoen, M., Hartog, A., Roeselers, G., MacKay, C. R. & Mebius, R. E., 1 Mar 2017, In : Journal of Immunology. 198, 5, p. 2172-2181 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Leukemic stem cells: identification and clinical application

Hanekamp, D., Cloos, J. & Schuurhuis, G. J., May 2017, In : American Journal of Hematology. 105, 5, p. 549-557 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models

Lin, F., de Gooijer, M. C., Hanekamp, D., Chandrasekaran, G., Buil, L. C. M., Thota, N., Sparidans, R. W., Beijnen, J. H., Würdinger, T. & van Tellingen, O., 1 Mar 2017, In : Clinical Cancer Research. 23, 5, p. 1286-1298 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

2016

CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia

Kersten, B., Valkering, M., Wouters, R., van Amerongen, R., Hanekamp, D., Kwidama, Z., Valk, P., Ossenkoppele, G., Zeijlemaker, W., Kaspers, G., Cloos, J. & Schuurhuis, G. J., Apr 2016, In : British Journal of Haematology. 173, 2, p. 219-235

Research output: Contribution to journalArticleAcademicpeer-review

2013

Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux

Lin, F., de Gooijer, M. C., Hanekamp, D., Brandsma, D., Beijnen, J. H. & van Tellingen, O., May 2013, In : CNS Oncology. 2, 3, p. 271-88 18 p.

Research output: Contribution to journalReview articleAcademicpeer-review